Venus Remedies LimitedNSE: VENUSREM

Press Release Jul 31 2023

· Issued by Venus Remedies Limited

Filed with NSE ·

Venus Remedies Limited has informed the Exchange regarding a press release dated July 31, 2023, titled "Venus Remedies oncology wing product registrations go up to 506 with marketing approvals from four more countries.".

View Attachment

6ix hasn’t read this filing yet.

Venus Remedies Limited on 6ix

Earlier from Venus Remedies

Later from Venus Remedies

All Venus Remedies news releases